Skip to main content
ARAY
NASDAQ Industrial Applications And Services

Accuray 10-K: $49M Loss, Adverse ICFR Opinion, and Covenant Breach Confirmed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.262
Mkt Cap
$31.305M
52W Low
$0.22
52W High
$2.1
52W Position info
19% above low
Off High info
88% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

ARAY sits 19% above its 52-week low of $0.22 on light trading volume (0.3× avg).

Summary

Accuray's FY2026 10-K reveals a $49.2M net loss, an adverse auditor opinion on internal controls, and confirmation of a minimum liquidity covenant breach as of June 30, 2026.


Key Events · Earnings and Guidance · ARAY

  • Adverse ICFR Opinion

    Grant Thornton issued an adverse opinion on internal control over financial reporting due to an unremediated material weakness in footnote schedule review. One prior material weakness was remediated, but the remaining one persists.

  • Covenant Breach Confirmed

    The company was not in compliance with the minimum liquidity covenant under the Amended Financing Agreement as of June 30, 2026. Lenders waived the default via Amendment No. 3 on July 29, 2026, which also provided a covenant holiday through December 31, 2027.

  • FY2026 Financial Results

    Net loss of $49.2M on revenue of $401.9M (down 12% YoY). Gross margin fell to 27.7% from 32.1%. Interest expense surged 154% to $32.9M due to the full-year impact of the June 2025 financing.

  • Restructuring Charges

    $16.2M in restructuring charges for FY2026, including elimination of approximately 15% of the global workforce during Q2 FY2026. The plan was substantially completed by June 30, 2026.


Analysis · ARAY · Industrial Applications And Services

Accuray's annual report confirms the severity of its distress. The auditor issued an adverse opinion on internal controls due to an unremediated material weakness, and the company admits it was not in compliance with its minimum liquidity covenant as of June 30, 2026. Full-year revenue fell 12% to $401.9M with a $49.2M net loss, while restructuring eliminated roughly 15% of the workforce. The stock trades at $0.26, far below the $1.00 Nasdaq minimum, and the company has until February 2, 2027 to regain compliance. The pending $55M recapitalization and reverse split — up for a shareholder vote on October 6 — are now the critical path to avoiding delisting and covenant default.

How filings like this one have moved

In the 30 days to Sep 11, 2026, 42.5% of the 522 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ARAY was trading at $0.26 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $31.3M. The 52-week trading range was $0.22 to $2.10. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARAY - Latest Insights

ARAY
Aug 24, 2026, 4:02 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.2716
Real-time Price: $0.240 info
Change: -$0.0316 (-12%) info
Market Cap: $29.024M info
ARAY
Aug 19, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $0.3001
Real-time Price: $0.240 info
Change: -$0.0601 (-20%) info
Market Cap: $29.024M info
ARAY
Aug 19, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3157
Real-time Price: $0.240 info
Change: -$0.0757 (-24%) info
Market Cap: $29.024M info
ARAY
Aug 12, 2026, 5:15 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.280
Real-time Price: $0.240 info
Change: -$0.040 (-14%) info
Market Cap: $29.024M info
ARAY
Jul 31, 2026, 7:00 AM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $0.283
Real-time Price: $0.240 info
Change: -$0.043 (-15%) info
Market Cap: $29.024M info